Epilepsy drug exposure in womb linked to significantly poorer school test results

March 26, 2018, British Medical Journal

Exposure to epilepsy drugs in the womb is linked to significantly poorer school test results among 7 year olds, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.

Mums-to-be need to be fully informed of the risks of treatment, but these should be weighed against the need for effective seizure control during , say the researchers.

Women with who need drugs to control their seizures are currently advised to continue taking them during pregnancy because convulsions can harm both mother and unborn child.

Several studies indicate that , particularly sodium valproate, taken during pregnancy, are associated with neurodevelopmental disorders, but few of these studies have been based on real life circumstances (population data).

To try and address this, the researchers used routinely collected healthcare information from the Secure Anonymous Information Linkage (SAIL) databank and national school test (key stage 1) data to compare the academic performance of 7 year olds in Wales born to mothers with epilepsy.

SAIL contains the anonymised primary care health records of 80 percent of Welsh family doctors, corresponding to around 77 percent of the Welsh population (2.3 million people).

The Key Stage 1 (KS1) test assesses maths, language (English/Welsh), and science among 7 year olds, scoring them from levels 1 to 3. Test results were available for 440 children whose mums had been diagnosed with epilepsy before their pregnancy for 2003 through to 2008.

Prescription patterns were divided into five categories: treatment with one drug (carbamazepine, lamotrigine or sodium valproate); a combination of several drugs; and no drug treatment.

Twenty (54%) of the 39 mums prescribed several drugs were taking sodium valproate, but there were 15 different combinations in all.

The results showed that children born to mums who had been prescribed carbamazepine or lamotrigine, or nothing, performed just as well as those born to mums of the same age and deprivation level, but without epilepsy (comparison group).

But those whose mums had been prescribed sodium valproate during their pregnancy performed 10.5 to just under 13 per cent less well on all KSI tests than those in the comparison group.

And children born to who had been prescribed a cocktail of epilepsy drugs achieved worse results still. Their scores were 19-22 percent lower.

Excluding children with epilepsy and whose mothers smoked from the analysis didn't materially change the results.

The researchers acknowledge that they weren't able to account for certain potentially influential factors, such as the mothers' IQ, weight or alcohol consumption; the doses of epilepsy drugs prescribed; or intake of folic acid around conception.

But their results echo those of other independent studies, they point out.

And they go on to say: "While this study highlights the risk of cognitive effects in the children of mothers prescribed sodium valproate or multiple [anti-epilepsy drugs], it is important to acknowledge that some epilepsies are difficult to treat without these treatment regimens."

And they recommend: "Women with epilepsy should be informed of this risk and alternative treatment regimens should be discussed before their pregnancy with a physician that specialises in epilepsy."

In a linked commentary, Dr Richard Chin of the University of Edinburgh's Muir Maxwell Epilepsy Centre, emphasises the importance of a study that is based on population data as this can be used to inform preventive/interventional strategies and help women to better understand the implications of epilepsy treatment while pregnant.

"By providing 'functional' outcome data from their study, the authors have now provided information that prospective parents may find readily tangible: it should be included in information given to women with epilepsy prior to pregnancy," he advocates.

Explore further: Exposure to antiepileptic drug in womb linked to autism risk

More information: Educational attainment of children born to mothers with epilepsy, DOI: 10.1136/jnnp-2017-317515

Commentary: AEDs or no AEDs during pregnancy? That is the question, DOI: 10.1136/jnnp-2017-317924

Related Stories

Exposure to antiepileptic drug in womb linked to autism risk

January 30, 2013
Children whose mothers take the antiepileptic drug sodium valproate while pregnant are at significantly increased risk of autism and other neurodevelopmental disorders, suggests a small study published online in the Journal ...

European experts advise against epilepsy drug in pregnancy

February 9, 2018
An expert committee of Europe's medicines watchdog recommended Friday that a drug used to treat epilepsy and linked to malformations in children not be used in pregnancy.

Does dosing of drug for mom make a difference for baby's risk of cleft lip, palate?

December 27, 2017
Taking a higher dose of topiramate during the first three months of pregnancy may increase a baby's risk of cleft lip or cleft palate more than when taking a lower dose, according to a study published in the December 27, ...

Expectant mothers with epilepsy face tough choices over their medication

October 29, 2014
A new study published today in The Cochrane Library, highlights the difficult decisions women with epilepsy have to face when they become pregnant. Taking certain drugs used to control epilepsy during pregnancy may be linked ...

Recommended for you

Neuroimaging study reveals 'hot spot' for cue-reactivity in substance-dependent population

November 20, 2018
When patients with dependence on alcohol, cocaine or nicotine are shown drug cues, or images related to the substance, an area of their brain known as the medial prefrontal cortex (mPFC) shows increased activity, report investigators ...

Being fair: The benefits of early child education

November 20, 2018
Children from low-income families who got intensive education early in life treat others with high levels of fairness in midlife, more than 40 years later, even when being fair comes at a high personal cost, according to ...

Does Netflix's '13 Reasons Why' influence teen suicide? Survey asks at-risk youths

November 20, 2018
A significant proportion of suicidal teens treated in a psychiatric emergency department said that watching the Netflix series "13 Reasons Why" had increased their suicide risk, a University of Michigan study finds.

MDMA makes people cooperative, but not gullible

November 19, 2018
New research from King's College London has found that MDMA, the main ingredient in ecstasy, causes people to cooperate better—but only with trustworthy people. In the first study to look in detail at how MDMA impacts cooperative ...

Exploring the genetic contribution to suicide risk

November 19, 2018
Researchers at University of Utah Health identified four gene changes that occur more frequently in people who died by suicide that may point to increased risk in vulnerable individuals.

Response to daily stressors could affect brain health in older adults

November 19, 2018
Taking typical daily annoyances such as a long wait at the doctor's office or a traffic jam on the freeway in stride may help preserve brain health in older adults, while emotional reactions could contribute to declines in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.